Completed PHASE3 INTERVENTIONAL 2-arm NCT01299766

Preventing Cognitive Decline in African Americans With Mild Cognitive Impairment

Sponsor: Dartmouth College

Conditions Mild Cognitive Impairment (MCI)

Interventions Behavioral Activation (BA) Supportive Therapy (ST)

Updated 10 times since 2017 Last updated: Nov 20, 2018 Started: Jun 21, 2011 Primary completion: Dec 13, 2016 Completion: Dec 13, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Mild Cognitive Impairment (MCI), this trial is completed. The trial is conducted by Dartmouth College and has accumulated 10 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Dec 2021 — Jul 2024 [monthly]

Completed PHASE3
Jan 2021 — Dec 2021 [monthly]

Completed PHASE3
Jan 2019 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 5 earlier versions

Dec 2018 — Jan 2019 [monthly]

Completed PHASE3
Jun 2018 — Dec 2018 [monthly]

Completed PHASE3
Feb 2018 — Jun 2018 [monthly]

Completed PHASE3

Status: Active Not Recruiting → Completed
May 2017 — Feb 2018 [monthly]

Active Not Recruiting PHASE3
Jan 2017 — May 2017 [monthly]

Active Not Recruiting PHASE3

First recorded

Jun 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Dartmouth College
Johns Hopkins University
National Institute on Aging (NIA)
Thomas Jefferson University
University of Pennsylvania

Data source: Thomas Jefferson University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Philadelphia, United States